• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Apthera

edit

Apthera, Inc., a biotechnology company, develops and produces peptide-based cancer immunotherapy solutions. It offers products for the treatment of breast and prostate cancers. The company was founded in 2005 and is based in Scottsdale, Arizona.

Recent Milestones

edit

• 
  Apthera was acquired by RXi Pharmaceuticals for $7M. (3/31/11)
  Posted 3/31/11 at 7:22pm via masshightech.com
• 
  Apthera added Mark W. Schwartz as President & CEO.
  Posted 3/31/11 at 7:21pm
• 
  Apthera added Robert E. Kennedy as CFO.
  Posted 3/31/11 at 7:21pm

Videos

Screenshots

edit

Sources

1. RXi buying Apthera for $7M, getting late-stage drug (masshightech.com) [edit]